Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Reference18 articles.
1. Hay I.D., Bergstralh E.J., Goellner J.R., Ebersold J.R., Grant C.S. Predicting outcome in papillary thyroid carcinoma: Development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at on institution during 1940 through 1989. Surgery 1993, 114: 1050–1058.
2. Mazzaferri E.L., Jiang S.M. Long-term impact of initial surgical and medical therapy on papillary and follicular cancer. Am. J. Med. 1994, 89: 418–428.
3. DeGroot L.J., Reilly M. Comparison of 30 and 50 mCi doses of iodine-131 for thyroid ablation. Ann. Intern. Med. 1982, 96: 51–53.
4. Maxon H.R. The role of 131-I in the treatment of thyroid cancer. In: J.H. Oppenheimer. (Ed.), Thyroid Today. 1993, vol. XVI, p.1.
5. Ladenson P.W., Braverman L.E., Mazzaferri E.L., Brucker-Davis F., Cooper D.S., Garber J.R., Wondisford F.E., Davies T.F., DeGroot L.J., Daniels G.H., Ross D.S., Weintraub B.D. Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive scanning of patients with thyroid carcinoma. N. Engl. J. Med. 1997, 337: 888–896.
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献